Identification of key pharmacological components and targets for Aidi injection in the treatment of pancreatic cancer by UPLC-MS, network pharmacology, and in vivo experiments.

Haojia WangZhishan WuXiaotian FanChao WuShan LuLibo GengAntony StalinYingli ZhuFanqin ZhangJiaqi HuangPengyun LiuHuiying LiLeiming YouJia-Rui Wu

Published in: Chinese medicine (2023)

ADI could reduce the growth rate of tumor tissue and alleviate the structural abnormalities in tumor tissue. ADI is predicted to act on VEGFA, P53, CASP3, and JUN in ADI-mediated treatment of pancreatic cancer.

Keyphrases

mass spectrometry
multiple sclerosis
ms ms